Skip to main content
ConductScienceScienceDex

Robert Babak Faryabi

NIH Rank #2409
Unclaimed recordClaim profile
  • Program Leader
  • R01 Holder
  • Translational
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 12159130Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Genetics
  • Pathology

NIH Funding · FY2025

Linked Award Amount
$3.6M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#2,409
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Robert Babak Faryabi. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Robert Babak Faryabi as a PI. Multi-PI records show the full award amount for context.

  • 2U01DK123594-06U01
    Human Pancreas Analysis Program for Type 2 Diabetes (HPAP-T2D)
    University of Pennsylvania
    $3M
    award amount
  • 5R01CA248041-04R01
    Epigenetic Mechanisms Underpinning Mantle Cell Lymphoma Sensitivity and Resistance to Notch Inhibitors
    University of Pennsylvania
    $418.3K
    award amount
  • 5R01CA230800-06R01
    Notch-driven Epigenetic Program of MYC and CCND1 in Triple-Negative Breast Cancer
    University of Pennsylvania
    $231.3K
    award amount

Award organization

Organizations that administered FY2025 awards listing Robert Babak Faryabi as a PI.

FY2025 award administered by University of Pennsylvania (PA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Pennsylvania
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #6183
  5. 2025
    $2M Cumulative Funding
  6. 2025
    $5M Cumulative Funding
  7. 2025
    Entered Top 25% Nationally
    Ranked #2409
  8. 2025
    R01 Grant Holder
  9. 2025
    Program/Center Grant Leader
  10. 2026
    $10M Cumulative Funding
  11. 2026
    Entered Top 10% Nationally
    Ranked #486
  12. 2026
    Entered Top 5% Nationally
    Ranked #486

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Robert Babak Faryabi.

Ali Naji
University of Pennsylvania
2
shared awards
Alvin C Powers
University of Pennsylvania
2
shared awards
Doris A Stoffers
University of Pennsylvania
2
shared awards
Klaus H Kaestner
University of Pennsylvania
2
shared awards
Alvin C Powers
Vanderbilt University Medical Center
1
shared award
Anna Louise Gloyn
Vanderbilt University Medical Center
1
shared award
Dirk Homann
Vanderbilt University Medical Center
1
shared award
Marcela Brissova
Vanderbilt University Medical Center
1
shared award
Mark A. Atkinson
Vanderbilt University Medical Center
1
shared award
Patrick MacDonald
Vanderbilt University Medical Center
1
shared award

Explore further

Find collaborators for Robert Babak Faryabi

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →